GlassScriptPhysician profile
John Lawrence Hudson
NPI 1184634537
$1,219.20
in general payments reported to CMS, 2019-2025
12 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $171 · 2021: $564 · 2022: $31.68 · 2023: $167 · 2024: $14.67 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zap Surgical Systems, INC. | $610.12 | 2020-2021 | |
| Boston Scientific Corporation | $140.80 | 2021-2025 | Patient Trial Kit |
| Penumbra, INC. | $122.94 | 2023 | Red 72 |
| Integra Lifesciences Corporation | $58.11 | 2019 | |
| Depuy Synthes Sales INC. | $55.92 | 2025 | Na |
| Celgene Corporation | $54.56 | 2022-2024 | Reblozyl |
| Gt Medical Technologies, INC | $52.65 | 2025 | Gammatile |
| Novocure INC. | $33.19 | 2019-2023 | Optune |
| Stryker Corporation | $31.65 | 2025 | Universal Neuro 3 |
| Emd Serono, INC. | $28.85 | 2019 | |
| Aesculap, INC. | $18.08 | 2022 | |
| Medical Device Business Services, INC. | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hudson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.